中国新药杂志2024,Vol.33Issue(11) :1093-1097.

构建药品审评公职科学家队伍的思考

Considerations on constructing the team of public scientists for drug evaluation

李峰 张婕颖 茅宁莹
中国新药杂志2024,Vol.33Issue(11) :1093-1097.

构建药品审评公职科学家队伍的思考

Considerations on constructing the team of public scientists for drug evaluation

李峰 1张婕颖 2茅宁莹2
扫码查看

作者信息

  • 1. 国家药品监督管理局新闻宣传中心,北京 100037
  • 2. 中国药科大学国际医药商学院,南京 211198
  • 折叠

摘要

本文结合医药行业创新发展对我国药品审评机构和能力提出的新要求,通过分析药品审评工作属性和职责定位,提出"公职科学家"概念,梳理其主要胜任力特征,并对建设及发展药品审评公职科学家队伍提出几点建议.

Abstract

The innovative development of pharmaceutical industry has brought new requirements to the Chinese institution of drug evaluation and its capabilities.This paper proposed the concept of"public service scientists",analyzed the attributes and responsibilities of drug review work,sorted out its main competency characteristics,and put forward some suggestions for constructing and developing public scientists for drug evaluation.

关键词

公职科学家/药品审评/胜任力特征

Key words

public scientist/drug evaluation/competency characteristics

引用本文复制引用

出版年

2024
中国新药杂志
中国医药科技出版社 中国医药集团总公司 中国药学会

中国新药杂志

CSTPCD北大核心
影响因子:1.039
ISSN:1003-3734
段落导航相关论文